Nanopharmacology in translational hematology and oncology

References

• de MoraisMGMartinsVGSteffensDPrankePda CostaJABiological applications of nanobiotechnologyJ Nanosci Nanotechnol20141411007101724730317
   PubMed Web of Science ®Google Scholar
• LiangXJNanotechnology and cancer nanomedicineBiotechnol Adv201432466524913056
   PubMed Web of Science ®Google Scholar
• SelvamuthukumarSVelmuruganRNanostructured lipid carriers: a potential drug carrier for cancer chemotherapyLipids Health Dis20121115923167765
   PubMed Web of Science ®Google Scholar
• SinghSSharmaARobertsonGPRealizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concernsCancer Res201272225663566823139207
   PubMed Web of Science ®Google Scholar
• OrzaASoriţăuOTomuleasaCReversing chemoresistance of malignant glioma stem cells using gold nanoparticlesInt J Nanomedicine2013868970223467447
   PubMed Web of Science ®Google Scholar
• TomuleasaCSoritauOOrzaAGold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cellsJ Gastrointestin Liver Dis201221218719622720309
   PubMed Web of Science ®Google Scholar
• RotelloVSniffing out cancer using “chemical nose” sensorsCell Cycle20098223615361619884794
   PubMed Web of Science ®Google Scholar
• YouCCMirandaORGiderBDetection and identification of proteins using nanoparticle-fluorescent polymer ‘chemical nose’ sensorsNat Nanotechnol20072531832318654291
   PubMed Web of Science ®Google Scholar
• LeonardRCWilliamsSTulpuleALevineAMOliverosSImproving the therapeutic index of anthracycline chemotherapy: focus on liposomal doxorubicin (Myocet)Breast200918421822419656681
   PubMed Web of Science ®Google Scholar
• PetrelliFBorgonovoKBarniSTargeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxelExpert Opin Pharmacother20101181413143220446855
   PubMed Web of Science ®Google Scholar
• BraicuCGhermanCDIrimieABerindan-NeagoeIEpigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cellsJ Nanosci Nanotechnol201313163263723646788
   PubMed Web of Science ®Google Scholar
• NeagoeIBBraicuCMateaCEfficient siRNA delivery system using carboxilated single-wall carbon nanotubes in cancer treatmentJ Biomed Nanotechnol20128456757422852466
   PubMed Web of Science ®Google Scholar
• ShangLNienhausKNienhausGUEngineered nanoparticles interacting with cells: size mattersJ Nanobiotechnology201412524491160
   PubMed Web of Science ®Google Scholar
• JulianoRLMingXNakagawaOCellular uptake and intracellular trafficking of antisense and siRNA oligonucleotidesBioconjug Chem201223214715721992697
   PubMed Web of Science ®Google Scholar
• Del BurgoLSPedrazJLOriveAdvanced nanovehicles for cancer managementDrug Discov Today2014
   Web of Science ®Google Scholar
• BashaRSabnisNHeymKBowmanWPLackoAGTargeted nanoparticles for pediatric leukemia therapyFront Oncol2014410124860784
   PubMedGoogle Scholar
• SinghRMukhopadhyayKSurvival analysis in clinical trials: Basics and must know areasPerspect Clin Res20112414514822145125
   PubMedGoogle Scholar
• MinkoTRodriguez-RodriguezLPozharovVNanotechnology approaches for personalized treatment of multidrug resistant cancersAdv Drug Deliv Rev20136513–141880189524120655
   PubMed Web of Science ®Google Scholar
• HedeSHuilgolN“Nano”: the new nemesis of cancerJ Cancer Res Ther20062418619517998702
   PubMedGoogle Scholar
• PanchapakesanBWickstromENanotechnology for sensing, imaging, and treating cancerSurg Oncol Clin N Am200716229330517560513
   PubMed Web of Science ®Google Scholar
• ThorntonGMaterials Science. Watching nanoparticles growScience200330056241378137912775827
   PubMedGoogle Scholar
• MoghimiSMHunterACMurrayJCNanomedicine: current status and future prospectsFASEB J200519331133015746175
   PubMed Web of Science ®Google Scholar
• UpretiMJyotiASethiPTumor microenvironment and nanotherapeuticsTransl Cancer Res20132430931924634853
   PubMed Web of Science ®Google Scholar
• DavisMEChenZGShinDMNanoparticle therapeutics: an emerging treatment modality for cancerNat Rev Drug Discov20087977178218758474
   PubMed Web of Science ®Google Scholar
• KopecekJKopeckováPMinkoTLuZRPetersonCMWater soluble polymers in tumor targeted deliveryJ Control Release2001741–314715811489491
   PubMed Web of Science ®Google Scholar
• ShenFChuSBenceAKQuantitation of doxorubicin uptake, efflux, and modulation of multidrug resistance (MDR) in MDR human cancer cellsJ Pharmacol Exp Ther200832419510217947497
   PubMed Web of Science ®Google Scholar
• ParkJWHongKKirpotinDBAnti-HER2 immunoliposomes: enhanced efficacy attributable to targeted deliveryClin Cancer Res2002841172118111948130
   PubMed Web of Science ®Google Scholar
• YuBMaoYYuanYTargeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cellsBiomaterials201334266185619323726226
   PubMed Web of Science ®Google Scholar
• LinYPanYShiYHuangXJiaNJiangJYDelivery of large molecules via poly(butyl cyanoacrylate) nanoparticles into the injured rat brainNanotechnology2012231616510122460562
   PubMed Web of Science ®Google Scholar
• DuanJMansourHMZhangYReversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticlesInt J Pharm20124261–219320122274587
   PubMed Web of Science ®Google Scholar
• ShenJMGaoFYYinTcRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapyPharmacol Res201370110211523376353
   PubMed Web of Science ®Google Scholar
• ShenJMGuanXMLiuXYLanJFChengTZhangHXLuminescent/magnetic hybrid nanoparticles with folate-conjugated peptide composites for tumor-targeted drug deliveryBioconjug Chem20122351010102122486419
   PubMed Web of Science ®Google Scholar
• ShenJMYinTTianXZGaoFYXuSSurface charge-switchable polymeric magnetic nanoparticles for the controlled release of anticancer drugACS Appl Mater Interfaces20135157014702423815399
   PubMed Web of Science ®Google Scholar
• MiklášováNFischer-FodorELönneckePAntiproliferative effect of novel platinum (II) and palladium (II) complexes on hepatic tumor stem cells in vitroEur J Med Chem201249414722305340
   PubMed Web of Science ®Google Scholar
• FlorianISTomuleasaCSoritauOCancer stem cells and malignant gliomas. From pathophysiology to targeted molecular therapyJ BUON2011161162321674845
   PubMed Web of Science ®Google Scholar
• TomuleasaCSoritauORus-CiucaDFunctional and molecular characterization of glioblastoma multiforme-derived cancer stem cellsJ BUON201015358359120941832
   PubMed Web of Science ®Google Scholar
• OzekiTKanekoDHashizawaKImaiYTagamiTOkadaHCombination therapy of surgical tumor resection with implantation of a hydrogel containing camptothecin-loaded poly(lactic-co-glycolic acid) microspheres in a C6 rat glioma modelBiol Pharm Bull201235454555022466559
   PubMed Web of Science ®Google Scholar
• OzekiTHashizawaKKanekoDImaiYOkadaHTreatment of rat brain tumors using sustained-release of camptothecin from poly(lactic-co-glycolic acid) microspheres in a thermoreversible hydrogelChem Pharm Bull (Tokyo)20105891142114720823591
   PubMed Web of Science ®Google Scholar
• AraiTJokiTAkiyamaMNovel drug delivery system using thermoreversible gelation polymer for malignant gliomaJ Neurooncol200677191516292493
   PubMed Web of Science ®Google Scholar
• DevalapallyHDuanZSeidenMVAmijiMMModulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticlesClin Cancer Res200814103193320318483388
   PubMed Web of Science ®Google Scholar
• RaimundoKBiskupiakJGoodmanMSilversteinSAscheCCost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS-Kaposi’s sarcomaJ Med Econ201316560661323425295
   PubMedGoogle Scholar
• ThierryARVigéDCoughlinSSBelliJADritschiloARahmanAModulation of doxorubicin resistance in multidrug-resistant cells by liposomesFASEB J1993765725798097173
   PubMed Web of Science ®Google Scholar
• BitounisDFanciullinoRIliadisACiccoliniJOptimizing druggability through liposomal formulations: new approaches to an old conceptISRN Pharm2012201273843222474607
   PubMedGoogle Scholar
• KlibanovALMaruyamaKTorchilinVPHuangLAmphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Lett199026812352372384160
   PubMed Web of Science ®Google Scholar
• MaruyamaKYudaTOkamotoAKojimaSSuginakaAIwatsuruMProlonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol)Biochim Biophys Acta19921128144491390877
   PubMedGoogle Scholar
• PapahadjopoulosDAllenTMGabizonASterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacyProc Natl Acad Sci U S A1991882411460114641763060
   PubMed Web of Science ®Google Scholar
• UsterPSAllenTMDanielBEMendezCJNewmanMSZhuGZInsertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation timeFEBS Lett19963862–32432468647291
   PubMed Web of Science ®Google Scholar
• HatakeyamaHAkitaHHarashimaHThe polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumorsBiol Pharm Bull201336689289923727912
   PubMed Web of Science ®Google Scholar
• MooberryLKNairMParanjapeSMcConathyWJLackoAGReceptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrierJ Drug Target2010181535819637935
   PubMed Web of Science ®Google Scholar
• BhattacharyaRMukherjeePBiological properties of “naked” metal nanoparticlesAdv Drug Deliv Rev200860111289130618501989
   PubMed Web of Science ®Google Scholar
• Oraki KohshourMMirzaieSZeinaliMAblation of breast cancer cells using trastuzumab-functionalized multi-walled carbon nanotubes and trastuzumab-diphtheria toxin conjugateChem Biol Drug Des201483325926524118702
   PubMed Web of Science ®Google Scholar
• ManjappaASGoelPNVekatarajuMPIs an alternative drug delivery system needed for docetaxel? The role of controlling epimerization in formulations and beyondPharm Res201330102675269323756759
   PubMed Web of Science ®Google Scholar
• SeoYGKimDHRamasamyTDevelopment of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effectInt J Pharm20134521–241242023707964
   PubMed Web of Science ®Google Scholar
• TempletonACWuelfingWPMurrayRWMonolayer-protected cluster moleculesAcc Chem Res2000331273610639073
   PubMed Web of Science ®Google Scholar
• ConnorEEMwamukaJGoleAMurphyCJWyattMDGold nanoparticles are taken up by human cells but do not cause acute cytotoxicitySmall20051332532717193451
   PubMed Web of Science ®Google Scholar
• BocaSCPotaraMGabudeanAMJuhemABaldeckPLAstileanSChitosan-coated triangular silver nanoparticles as a novel class of biocompatible, highly effective photothermal transducers for in vitro cancer cell therapyCancer Lett2011311213114021840122
   PubMed Web of Science ®Google Scholar
• SuarasanSFocsanMManiuDAstileanSGelatin-nanogold bioconjugates as effective plasmonic platforms for SERS detection and taggingColloids Surf B Biointerfaces201310347548123261569
   PubMed Web of Science ®Google Scholar
• GabudeanAMBiroDAstileanSHybrid plasmonic platforms based on silica-encapsulated gold nanorods as effective spectroscopic enhancers for Raman and fluorescence spectroscopyNanotechnology2012234848570623138835
   PubMed Web of Science ®Google Scholar
• FocsanMArdeleanIICraciunCAstileanSInterplay between gold nanoparticle biosynthesis and metabolic activity of cyanobacterium Synechocystis sp. PCC 6803Nanotechnology2011224848510122072064
   PubMed Web of Science ®Google Scholar
• PotaraMManiuDAstileanSThe synthesis of biocompatible and SERS-active gold nanoparticles using chitosanNanotechnology2009203131560219597258
   PubMed Web of Science ®Google Scholar
• BocaSCAstileanSDetoxification of gold nanorods by conjugation with thiolated poly(ethylene glycol) and their assessment as SERS-active carriers of Raman tagsNanotechnology2010212323560120463383
   PubMed Web of Science ®Google Scholar
• AldeaMDPetrushevBSoritauOMetformin plus sorafenib highly impacts temozolomideresistant glioblastoma stem-like cellsJ BUON20141925021124965413
   PubMed Web of Science ®Google Scholar
• XiGRobinsonEMania-FarnellBConvection-enhanced delivery of nanodiamond drug delivery platforms for intracranial tumor treatmentNanomedicine201410238139123916888
   PubMed Web of Science ®Google Scholar
• ManHBKimHKimHJSynthesis of nanodiamond-daunorubicin conjugates to overcome multidrug chemoresistance in leukemiaNanomedicine201410235936923916889
   PubMed Web of Science ®Google Scholar
• CirpanliYBilensoyELale DoğanACalişSComparative evaluation of polymeric and amphiphilic cyclodextrin nanoparticles for effective camptothecin deliveryEur J Pharm Biopharm2009731828919442723
   PubMed Web of Science ®Google Scholar
• SoukaseneSToftDJMoyerTJAntitumor activity of peptide amphiphile nanofiber-encapsulated camptothecinACS Nano20115119113912122044255
   PubMed Web of Science ®Google Scholar
• MinKHParkKKimYSHydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapyJ Control Release2008127320821818336946
   PubMed Web of Science ®Google Scholar
• BaruaSYooJWKolharPWakankarAGokarnYRMitragotriSParticle shape enhances specificity of antibody-displaying nanoparticlesProc Natl Acad Sci U S A201311093270327523401509
   PubMed Web of Science ®Google Scholar
• NiGWangYWuXWangXChenSLiuXGraphene oxide absorbed anti-IL10R antibodies enhance LPS induced immune responses in vitro and in vivoImmunol Lett2012148212613223064239
   PubMed Web of Science ®Google Scholar
• JaganathanHMitraSSrinivasanSDaveBGodinBDesign and in vitro evaluation of layer by layer siRNA nanovectors targeting breast tumor initiating cellsPLoS One2014 Apr 294e9198624694753
   PubMed Web of Science ®Google Scholar
• DavisMEThe first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinicMol Pharm20096365966819267452
   PubMed Web of Science ®Google Scholar
• van VlerkenLEAmijiMMMulti-functional polymeric nanoparticles for tumour-targeted drug deliveryExpert Opin Drug Deliv20063220521616506948
   PubMedGoogle Scholar
• SunCSzeRZhangMFolic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRIJ Biomed Mater Res A200678355055716736484
   PubMed Web of Science ®Google Scholar
• MedarovaZPhamWFarrarCPetkovaVMooreAIn vivo imaging of siRNA delivery and silencing in tumorsNat Med200713337237717322898
   PubMed Web of Science ®Google Scholar
• GunnJWallenHVeisehOA multimodal targeting nanoparticle for selectively labeling T cellsSmall20084671271518528851
   PubMed Web of Science ®Google Scholar
• VeisehOKievitFMGunnJWRatnerBDZhangMA ligand-mediated nanovector for targeted gene delivery and transfection in cancer cellsBiomaterials200930464965718990439
   PubMed Web of Science ®Google Scholar
• LewinMCarlessoNTungCHTat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cellsNat Biotechnol200018441041410748521
   PubMed Web of Science ®Google Scholar
• HarisinghaniMGBarentszJHahnPFNoninvasive detection of clinically occult lymph-node metastases in prostate cancerN Engl J Med2003348252491249912815134
   PubMed Web of Science ®Google Scholar
• WadajkarASMenonJUKadapureTTranRTYangJNguyenKTDesign and application of magnetic-based theranostic nanoparticle systemsRecent Pat Biomed Eng201361475723795343
   PubMedGoogle Scholar
• VlasovaMARytkönenJRiikonenJNanocarriers and the delivered drug: Effect interference due to intravenous administrationEur J Pharm Sci2014
   PubMed Web of Science ®Google Scholar
• BabincováMKontrisovaKDurdíkSBergemannCSourivongPRadiation enhanced efficiency of combined electromagnetic hyperthermia and chemotherapy of lung carcinoma using cisplatin functionalized magnetic nanoparticlesPharmazie201469212813124640602
   PubMed Web of Science ®Google Scholar
• ChandaNKanPWatkinsonLDRadioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing miceNanomedicine20106220120919914401
   PubMed Web of Science ®Google Scholar
• GarrisonJCRoldTLSieckmanGLIn vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systemsJ Nucl Med20074881327133717631556
   PubMed Web of Science ®Google Scholar
• El-AneedAAn overview of current delivery systems in cancer gene therapyJ Control Release200494111414684267
   PubMed Web of Science ®Google Scholar
• MintzerMASimanekEENonviral vectors for gene deliveryChem Rev2009109225930219053809
   PubMed Web of Science ®Google Scholar
• BoussifOLezoualc’hFZantaMAA versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimineProc Natl Acad Sci U S A19959216729773017638184
   PubMed Web of Science ®Google Scholar
• SwamiAGoyalRTripathiSKEffect of homobifunctional crosslinkers on nucleic acids delivery ability of PEI nanoparticlesInt J Pharm20093741–212513819446769
   PubMedGoogle Scholar
• OhYKSuhDKimJMChoiHGShinKKoJJPolyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNAGene Ther20029231627163212424615
   PubMed Web of Science ®Google Scholar
• XuPLiSYLiQBiodegradable cationic polyester as an efficient carrier for gene delivery to neonatal cardiomyocytesBiotechnol Bioeng200695589390317001632
   PubMed Web of Science ®Google Scholar
• FloreaBIMeaneyCJungingerHEBorchardGTransfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell culturesAAPS Pharm Sci200243E12
   PubMed Web of Science ®Google Scholar
• EllingtonADSzostakJWIn vitro selection of RNA molecules that bind specific ligandsNature199034662878188221697402
   PubMed Web of Science ®Google Scholar
• TuerkCGoldLSystematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymeraseScience199024949685055102200121
   PubMed Web of Science ®Google Scholar
• JenisonRDGillSCPardiAPoliskyBHigh-resolution molecular discrimination by RNAScience19942635152142514297510417
   PubMed Web of Science ®Google Scholar
• LeeYMiyataKObaMCharge-conversion ternary polyplex with endosome disruption moiety: a technique for efficient and safe gene deliveryAngew Chem Int Ed Engl200847285163516618528828
   PubMed Web of Science ®Google Scholar
• XuPVan KirkEAZhanYMurdochWJRadoszMShenYTargeted charge-reversal nanoparticles for nuclear drug deliveryAngew Chem Int Ed Engl200746264999500217526044
   PubMed Web of Science ®Google Scholar
• ShenYZhouZSuiMCharge-reversal polyamidoamine dendrimer for cascade nuclear drug deliveryNanomedicine (Lond)2010581205121721039198
   PubMed Web of Science ®Google Scholar
• RozemaDBEkenaKLewisDLLoomisAGWolffJAEndosomolysis by masking of a membrane-active agent (EMMA) for cytoplasmic release of macromoleculesBioconjug Chem2003141515712526692
   PubMed Web of Science ®Google Scholar
• MiyataKObaMNakanishiMPolyplexes from poly(aspartamide) bearing 1,2-diaminoethane side chains induce pH-selective, endosomal membrane destabilization with amplified transfection and negligible cytotoxicityJ Am Chem Soc200813048162871629419006313
   PubMed Web of Science ®Google Scholar
• LiuXZhangJLynnDMPolyelectrolyte multilayers fabricated from ‘charge-shifting’ anionic polymers: a new approach to controlled film disruption and the release of cationic agents from surfacesSoft Matter2008481688169519122876
   PubMed Web of Science ®Google Scholar
• BaoQShiYApoptosome: a platform for the activation of initiator caspasesCell Death Differ2007141566516977332
   PubMed Web of Science ®Google Scholar
• MannaPGhoshMGhoshJDasJSilPCContribution of nano-copper particles to in vivo liver dysfunction and cellular damage: role of IκBα/NF-κB, MAPKs and mitochondrial signalNanotoxicology20126112121319953
   PubMed Web of Science ®Google Scholar
• JeongJHParkTGNovel polymer-DNA hybrid polymeric micelles composed of hydrophobic poly(D,L-lactic-co-glycolic acid) and hydrophilic oligonucleotidesBioconjug Chem201112691792311716682
   PubMedGoogle Scholar
• KataokaKItakaKNishiyamaNYamasakiYOishiMNagasakiYSmart polymeric micelles as nanocarriers for oligonucleotides and siRNA deliveryNucleic Acids Symp Ser (Oxf)2005491718
   PubMedGoogle Scholar
• LiuJLuYFast colorimetric sensing of adenosine and cocaine based on a general sensor design involving aptamers and nanoparticlesAgnew Chem Int Ed Engl20054519094
   PubMed Web of Science ®Google Scholar
• YangHLiuHKangHTanWEngineering target-responsive hydrogels based on aptamer-target interactionsJ Am Chem Soc2008130206320632118444626
   PubMed Web of Science ®Google Scholar
• MarcusMELeonardJNFedExosomes: engineering therapeutic biological nanoparticles that truly deliverPharmaceuticals (Basel)20136565968023894228
   PubMedGoogle Scholar
• EL AndaloussiSMägerIBreakefieldXOWoodMJExtracellular vesicles: biology and emerging therapeutic opportunitiesNat Rev Drug Discov201312534735723584393
   PubMed Web of Science ®Google Scholar
• KowalJTkachMThéryCBiogenesis and secretion of exosomes201429116125
   Google Scholar
• ValadiHEkströmKBossiosASjöstrandMLeeJJLötvallJOExosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNat Cell Biol20079665465917486113
   PubMed Web of Science ®Google Scholar
• NazarenkoIRuppAKAltevogtPExosomes as a potential tool for a specific delivery of functional moleculesMethods Mol Biol2013104949551123913240
   PubMedGoogle Scholar
• TicknerJAUrquhartAJStephensonSARichardDJO’ByrneKJFunctions and therapeutic roles of exosomes in cancerFront Oncol2014412724904836
   PubMedGoogle Scholar
• LehrmanSVirus treatment questioned after gene therapy deathNature1999401675351751810524611
   PubMed Web of Science ®Google Scholar
• KogaKMatsumotoKAkiyoshiTPurification, characterization and biological significance of tumor-derived exosomesAnticancer Res2005256A3703370716302729
   PubMed Web of Science ®Google Scholar
• CastanottoDRossiJJThe promises and pitfalls of RNA-interference-based therapeuticsNature2009457722842643319158789
   PubMed Web of Science ®Google Scholar
• WahlgrenJDeLKarlsonTBrisslertMPlasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytesNucleic Acids Res20124017e13022618874
   PubMed Web of Science ®Google Scholar
• Alvarez-ErvitiLSeowYYinHBettsCLakhalSWoodMJDelivery of siRNA to the mouse brain by systemic injection of targeted exosomesNat Biotechnol201129434134521423189
   PubMed Web of Science ®Google Scholar
• El-AndaloussiSLeeYLakhal-LittletonSExosome-mediated delivery of siRNA in vitro and in vivoNat Protoc20127122112212623154783
   PubMed Web of Science ®Google Scholar
• BraicuCCalinGABerindan-NeagoeIMicroRNAs and cancer therapy - from bystanders to major playersCurr Med Chem201320293561357323834177
   PubMed Web of Science ®Google Scholar
• GarzonRMarcucciGCroceCMTargeting microRNAs in cancer: rationale, strategies and challengesNat Rev Drug Discov201091077578920885409
   PubMed Web of Science ®Google Scholar
• JichaGACarrSAConceptual Evolution in Alzheimer’s Disease: Implications for Understanding the Clinical Phenotype of Progressive Neurodegenerative DiseaseJ Alzheimers Dis201019125327220061643
   PubMed Web of Science ®Google Scholar
• FreddiGRomàn-PumarJLEvidence-based medicine: what it can and cannot doAnn Ist Super Sanita2011471222521430334
   PubMed Web of Science ®Google Scholar
• SinghSLokeYKDrug safety assessment in clinical trials: methodological challenges and opportunitiesTrials20121313822906139
   PubMed Web of Science ®Google Scholar
• HaoLPatelPCAlhasanAHGiljohannDAMirkinCANucleic acid-gold nanoparticle conjugates as mimics of microRNASmall20117223158316221922667
   PubMed Web of Science ®Google Scholar
• BhayaniMKCalinGALaiSYFunctional relevance of miRNA sequences in human diseaseMutat Res20127311–2141922085809
   PubMed Web of Science ®Google Scholar
• MunkerRCalinGAMicroRNA profiling in cancerClin Sci (Lond)2011121414115821526983
   PubMed Web of Science ®Google Scholar
• FabbriMCalinGAEpigenetics and miRNAs in human cancerAdv Genet201070879920920746
   PubMed Web of Science ®Google Scholar
• SantarpiaLNicolosoMCalinGAMicroRNAs: a complex regulatory network drives the acquisition of malignant cell phenotypeEndocr Relat Cancer2010171F51F7519843580
   PubMed Web of Science ®Google Scholar
• CalinGACroceCMChronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genesBlood2009114234761477019745066
   PubMed Web of Science ®Google Scholar
• GarzonRCalinGACroceCMMicroRNAs in CancerAnnu Rev Med20096016717919630570
   PubMed Web of Science ®Google Scholar
• NegriniMNicolosoMSCalinGAMicroRNAs and cancer – new paradigms in molecular oncologyCurr Opin Cell Biol200921347047919411171
   PubMed Web of Science ®Google Scholar
• VisoneRCroceCMMiRNAs and cancerAm J Pathol200917441131113819264914
   PubMed Web of Science ®Google Scholar
• MauritzKHPeckhamHPRestoration of grasping functions in quadriplegic patients by Functional Electrical Stimulation (FES)Int J Rehabil Res1987104 Suppl 557613509753
   PubMedGoogle Scholar
• PalmeroEIde CamposSGCamposMMechanisms and role of microRNA deregulation in cancer onset and progressionGenet Mol Biol201134336337021931505
   PubMed Web of Science ®Google Scholar
• ZhouXXWangXRole of microRNAs in chronic lymphocytic leukemia (Review)Mol Med Rep20138371972523900739
   PubMed Web of Science ®Google Scholar
• CalinGACimminoAFabbriMMiR-15a and miR-16-1 cluster functions in human leukemiaProc Natl Acad Sci U S A2008105135166517118362358
   PubMed Web of Science ®Google Scholar
• RaoEJiangCJiMThe miRNA-17~92 cluster mediates chemoresistance and enhances tumor growth in mantle cell lymphoma via PI3K/AKT pathway activationLeukemia20122651064107222116552
   PubMed Web of Science ®Google Scholar
• LiebermanRCalifanoPRoentgenographic manifestations of gout. A case reportJ Am Podiatr Med Assoc19877795065093668829
   PubMed Web of Science ®Google Scholar
• VenturiniLBattmerKCastoldiMExpression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cellsBlood2007109104399440517284533
   PubMed Web of Science ®Google Scholar
• RommerASteinleitnerKHacklHOverexpression of primary microRNA 221/222 in acute myeloid leukemiaBMC Cancer20131336423895238
   PubMed Web of Science ®Google Scholar
• Gimenes-TeixeiraHLLucena-AraujoARDos SantosGAIncreased expression of miR-221 is associated with shorter overall survival in T-cell acute lymphoid leukemiaExp Hematol Oncol2013211023566596
   PubMedGoogle Scholar
• GarzonRHeaphyCEHavelangeVMicroRNA 29b functions in acute myeloid leukemiaBlood2009114265331534119850741
   PubMed Web of Science ®Google Scholar
• MarcucciGMaharryKSMetzelerKHClinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patientsJ Clin Oncol201331172086209323650424
   PubMed Web of Science ®Google Scholar
• Akbari MoqadamFLange-TurenhoutEAAriësIMPietersRden BoerMLMiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemiaLeuk Res201337101315132123915977
   PubMed Web of Science ®Google Scholar
• AqeilanRICalinGACroceCMmiR-15a and miR-16-1 in cancer: discovery, function and future perspectivesCell Death Differ201017221522019498445
   PubMed Web of Science ®Google Scholar
• PekarskyYSantanamUCimminoATcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181Cancer Res20066624115901159317178851
   PubMed Web of Science ®Google Scholar
• MosakhaniNMustjokiSKnuutilaSDown-regulation of miR-181c in imatinib-resistant chronic myeloid leukemiaMol Cytogenet2013612723866735
   PubMedGoogle Scholar
• LiuYSongYMaWZhengWYinHDecreased microRNA-30a levels are associated with enhanced ABL1 and BCR-ABL1 expression in chronic myeloid leukemiaLeuk Res201337334935623287430
   PubMed Web of Science ®Google Scholar
• MatsumuraYMaedaHA new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancsCancer Res19864612 Pt 1638763922946403
   PubMed Web of Science ®Google Scholar
• GreishKEnhanced permeability and retention (EPR) effect for anticancer nanomedicine drug targetingMethods Mol Biol2010624253720217587
   PubMedGoogle Scholar
• ZyslerRDLimaEJrVasquez MansillaMA new quantitative method to determine the uptake of SPIONs in animal tissue and its application to determine the quantity of nanoparticles in the liver and lung of Balb-c mice exposed to the SPIONsJ Biomed Nanotechnol20139114214523627077
   PubMed Web of Science ®Google Scholar
• PradosJMelguizoCPerazzoliGApplication of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patentsRecent Pat Anticancer Drug Discov201491213423676104
   PubMed Web of Science ®Google Scholar
• De JongWHBormPJDrug delivery and nanoparticles: applications and hazardsInt J Nanomedicine20083213314918686775
   PubMed Web of Science ®Google Scholar
• LeucutaSENanotechnology for delivery of drugs and biomedical applicationsCurr Clin Pharmacol20105425728020925643
   PubMedGoogle Scholar
• AlexisFPridgenEMLangerRFarokhzadOCNanoparticle technologies for cancer therapyHandb Exp Pharmacol2010197558620217526
   PubMedGoogle Scholar
• FarokhzadOCChengJTeplyBATargeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivoProc Natl Acad Sci U S A2006103166315632016606824
   PubMed Web of Science ®Google Scholar
• LeePCChiouYCWongJMPengCLShiehMJTargeting colorectal cancer cells with single-walled carbon nanotubes conjugated to anticancer agent SN-38 and EGFR antibodyBiomaterials201334348756876523937913
   PubMed Web of Science ®Google Scholar
• ShiJMaRWangLThe application of hyaluronic acid-derivatized carbon nanotubes in hematoporphyrin monomethyl ether-based photodynamic therapy for in vivo and in vitro cancer treatmentInt J Nanomedicine201382361237323843694
   PubMed Web of Science ®Google Scholar
• LiXGaoJYangYNanomaterials in the application of tumor vaccines: advantages and disadvantagesOnco Targets Ther2013662963423776336
   PubMed Web of Science ®Google Scholar
• LiuZFanACRakhraKSupramolecular stacking of doxorubicin on carbon nanotubes for in vivo cancer therapyAngew Chem Int Ed Engl200948417668767219760685
   PubMed Web of Science ®Google Scholar
• CoelhoSCRochaSJuzenasPGold nanoparticle delivery-enhanced proteasome inhibitor effect in adenocarcinoma cellsExpert Opin Drug Deliv201310101345135223937147
   PubMed Web of Science ®Google Scholar
• LiKWenSLarsonACMultifunctional dendrimer-based nanoparticles for in vivo MR/CT dual-modal molecular imaging of breast cancerInt J Nanomedicine201382589260023888113
   PubMed Web of Science ®Google Scholar
• FarrokhTakinECiofaniGPuleoGLBarium titanate core – gold shell nanoparticles for hyperthermia treatmentsInt J Nanomedicine201382319233123847415
   PubMed Web of Science ®Google Scholar
• WangHJYangLYangHYAntineoplastic activities of protein-conjugated silver sulfide nano-crystals with different shapesJ Inorg Biochem20101041879119906430
   PubMed Web of Science ®Google Scholar
• PietiläMLehenkariPKuvajaPMortalin antibody-conjugated quantum dot transfer from human mesenchymal stromal cells to breast cancer cells requires cell-cell interactionExp Cell Res2013319182770278023928292
   PubMed Web of Science ®Google Scholar
• ZhangCJiXZhangYOne-pot synthesized aptamer-functionalized CdTe:Zn2+ quantum dots for tumor-targeted fluorescence imaging in vitro and in vivoAnal Chem201385125843584923682757
   PubMed Web of Science ®Google Scholar
• Daldrup-LinkHERummenyEJIhssenBKienastJLinkTMIron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin’s lymphoma: differentiation between tumor infiltration and hypercellular bone marrowEur Radiol20021261557156612042968
   PubMed Web of Science ®Google Scholar
• DelsolGThe 2008 WHO lymphoma classificationAnn Pathol200828Spec No 1(1)S20S24 French18984289
   PubMedGoogle Scholar
• FaliniBPileriSZinzaniPLALK+ lymphoma: clinic-pathological findings and outcomeBlood19999382697270610194450
   PubMed Web of Science ®Google Scholar
• SteinHFossHDDürkopHCD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical featuresBlood200096123681369511090048
   PubMed Web of Science ®Google Scholar
• RitterUDamm-WelkCFuchsUBohleRMBorkhardtAWoessmannWDesign and evaluation of chemically synthesized siRNA targeting the NPM-ALK fusion site in anaplastic large cell lymphoma (ALCL)Oligonucleotides200313536537315000827
   PubMed Web of Science ®Google Scholar
• PivaRChiarleRManazzaADAblation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomasBlood2006107268969716189272
   PubMed Web of Science ®Google Scholar
• MoriTOguroAOhtsuTNakamuraYRNA aptamers selected against the receptor activator of NF-kappaB acquire general affinity to proteins of the tumor necrosis factor receptor familyNucleic Acids Res200432206120612815562003
   PubMed Web of Science ®Google Scholar
• ZhaoNBagariaHGWongMSZuYA nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphomaJ Nanobiotechnology20119221281497
   PubMed Web of Science ®Google Scholar
• SemeteBBooysenLLemmerYIn vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systemsNanomedicine20106566267120230912
   PubMed Web of Science ®Google Scholar
• WitzigTECurrent treatment approaches for mantle-cell lymphomaJ Clin Oncol200523266409641416155027
   PubMed Web of Science ®Google Scholar
• WilliamsMEConnorsJMDreylingMHMantle cell lymphoma: report of the 2010 Mantle Cell Lymphoma Consortium WorkshopLeuk Lymphoma2011521243321133727
   PubMed Web of Science ®Google Scholar
• DelmonteAGhielminiMSessaCBeyond monoclonal antibodies: new therapeutic agents in non-Hodgkin’s lymphomasOncologist200914551152519411316
   PubMed Web of Science ®Google Scholar
• HessGNew combinations for mantle cell lymphoma: concerted action neededLancet Oncol201112431531621440504
   PubMed Web of Science ®Google Scholar
• UckunFMQaziSSpleen tyrosine kinase as a molecular target for treatment of leukemias and lymphomasExpert Rev Anticancer Ther20101091407141820836676
   PubMed Web of Science ®Google Scholar
• UckunFMEkROJanSTChenCLQaziSTargeting SYK kinase-dependent anti-apoptotic resistance pathway in B-lineage acute lymphoblastic leukaemia (ALL) cells with a potent SYK inhibitory pentapeptide mimicBr J Haematol2010149450851720151979
   PubMed Web of Science ®Google Scholar
• UckunFMGoodmanPMaHDibirdikIQaziSCD22 EXON 12 deletion as a pathogenic mechanism of human B-precursor leukemiaProc Natl Acad Sci U S A201010739168521685720841423
   PubMed Web of Science ®Google Scholar
• CelyIYivSYinQTargeting mantle cell lymphoma with anti-SYK nanoparticlesJ Anal Oncol2012111923730399
   PubMedGoogle Scholar
• MuggiaFMHainsworthJDJeffersSPhase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulationJ Clin Oncol19971539879939060537
   PubMed Web of Science ®Google Scholar
• MuggiaFMClinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancersDrugs199754Suppl 422299361958
   PubMed Web of Science ®Google Scholar
• ShenCBrozenaAHWangYDouble-walled carbon nanotubes: challenges and opportunitiesNanoscale20113250351821042608
   PubMed Web of Science ®Google Scholar
• HuangNWangHZhaoJLuiHKorbelikMZengHSingle-wall carbon nanotubes assisted photothermal cancer therapy: animal study with a murine model of squamous cell carcinomaLasers Surg Med201042963864820949599
   PubMed Web of Science ®Google Scholar
• ThakareVSDasMJainAKPatilSJainSCarbon nanotubes in cancer theragnosisNanomedicine (Lond)2010581277130121039202
   PubMed Web of Science ®Google Scholar
• JiSRLiuCZhangBCarbon nanotubes in cancer diagnosis and therapyBiochim Biophys Acta201018061293520193746
   PubMed Web of Science ®Google Scholar
• LiuZTabakmanSWelsherKDaiHCarbon nanotubes in biology and medicine: in vitro and in vivo detection, imaging and drug deliveryNano Res2009228512020174481
   PubMed Web of Science ®Google Scholar
• LiuZChenKDavisCDrug delivery with carbon nanotubes for in vivo cancer treatmentCancer Res200868166652666018701489
   PubMed Web of Science ®Google Scholar
• ChaudhuriPSoniSSenguptaSSingle-walled carbon nanotube-conjugated chemotherapy exhibits increased therapeutic index in melanomaNanotechnology201021202510219955607
   PubMed Web of Science ®Google Scholar
• SatsangiARoySSSatsangiRKVadlamudiRKOngJLDesign of a Paclitaxel prodrug conjugate for active targeting of an enzyme upregulated in breast cancer cellsMol Pharm20141161906191824847940
   PubMedGoogle Scholar
• SinghSNalwaHSNanotechnology and health safety – toxicity and risk assessments of nanostructured materials on human healthJ Nanosci Nanotechnol2007793048307018019130
   PubMed Web of Science ®Google Scholar
• RadomskiAJuraszPAlonso-EscolanoDNanoparticle-induced platelet aggregation and vascular thrombosisBr J Pharmacol2005146688289316158070
   PubMed Web of Science ®Google Scholar
• SayesCMLiangFHudsonJLFunctionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitroToxicol Lett2006161213514216229976
   PubMed Web of Science ®Google Scholar
• ShvedovaAACastranovaVKisinERExposure to carbon nanotube material: assessment of nanotube cytotoxicity using human keratinocyte cellsJ Toxicol Environ Health A200366201909192614514433
   PubMed Web of Science ®Google Scholar
• WarheitDBLaurenceBRReedKLRoachDHReynoldsGAWebbTRComparative pulmonary toxicity assessment of single-wall carbon nanotubes in ratsToxicol Sci200477111712514514968
   PubMed Web of Science ®Google Scholar
• RavichandranPPeriyakaruppanASadanandanBInduction of apoptosis in rat lung epithelial cells by multiwalled carbon nanotubesJ Biochem Mol Toxicol200923533334419827037
   PubMed Web of Science ®Google Scholar
• ReddyARReddyYNKrishnaDRHimabinduVPulmonary toxicity assessment of multiwalled carbon nanotubes in rats following intratracheal instillationEnviron Toxicol201227421121920862737
   PubMed Web of Science ®Google Scholar
• MullerJHuauxFMoreauNRespiratory toxicity of multi-wall carbon nanotubesToxicol Appl Pharmacol2005207322123116129115
   PubMed Web of Science ®Google Scholar
• LooCLinAHirschLNanoshell-enabled photonics-based imaging and therapy of cancerTechnol Cancer Res Treat200431334014750891
   PubMed Web of Science ®Google Scholar
• NiidomeTYamagataMOkamotoYPEG-modified gold nanorods with a stealth character for in vivo applicationsJ Control Release2006114334334716876898
   PubMed Web of Science ®Google Scholar
• KawanoTYamagataMTakahashiHStabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulsesJ Control Release2006111338238916487614
   PubMed Web of Science ®Google Scholar
• HainfeldJFSlatkinDNSmilowitzHMThe use of gold nanoparticles to enhance radiotherapy in micePhys Med Biol20044918N309N31515509078
   PubMed Web of Science ®Google Scholar
• SimonTBoca-FarcauSGabudeanAMBaldeckPAstileanSLED-activated methylene blue-loaded Pluronic-nanogold hybrids for in vitro photodynamic therapyJ Biophotonics2013611–1295095923893922
   PubMed Web of Science ®Google Scholar
• BocaSRuginaDPinteaABarbu-TudoranLAstileanSFlower-shaped gold nanoparticles: synthesis, characterization and their application as SERS-active tags inside living cellsNanotechnology201122505570221178234
   PubMed Web of Science ®Google Scholar
• O’NealDPHirschLRHalasNJPayneJDWestJLPhoto-thermal tumor ablation in mice using near infrared-absorbing nanoparticlesCancer Lett2004209217117615159019
   PubMed Web of Science ®Google Scholar
• WaldmanSAFortinaPSurreySHyslopTKrickaLJGravesDJOpportunities for near-infrared thermal ablation of colorectal metastases by guanylyl cyclase C-targeted gold nanoshellsFuture Oncol20062670571617155897
   PubMedGoogle Scholar
• ShahverdiARFakhimiAShahverdiHRMinaianSSynthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coliNanomedicine20073216817117468052
   PubMed Web of Science ®Google Scholar
• SondiISalopek-SondiBSilver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteriaJ Colloid Interface Sci2004275117718215158396
   PubMed Web of Science ®Google Scholar
• CoulterJAHylandWBNicolJCurrellFJRadiosensitising nanoparticles as novel cancer therapeutics – pipe dream or realistic prospect?Clin Oncol (R Coll Radiol)2013251059360323876527
   PubMed Web of Science ®Google Scholar
• SatapathySRMohapatraPPreetRSilver-based nanoparticles induce apoptosis in human colon cancer cells mediated through p53Nanomedicine (Lond)2013881307132223514434
   PubMed Web of Science ®Google Scholar
• KempMMKumarAMousaSGold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis propertiesNanotechnology2009204545510419822927
   PubMed Web of Science ®Google Scholar
• SriramMIKanthSBKalishwaralalKGurunathanSAntitumor activity of silver nanoparticles in Dalton’s lymphoma ascites tumor modelInt J Nanomedicine2010575376221042421
   PubMed Web of Science ®Google Scholar
• GrosseSEvjeLSyversenTSilver nanoparticle-induced cytotoxicity in rat brain endothelial cell cultureToxicol In Vitro201327130531322954533
   PubMed Web of Science ®Google Scholar
• SharmaHSSharmaANeurotoxicity of engineered nanoparticles from metalsCNS Neurol Disord Drug Targets2012111658022229317
   PubMed Web of Science ®Google Scholar
• PowersCMLevinEDSeidlerFJSlotkinTASilver exposure in developing zebrafish produces persistent synaptic and behavioral changesNeurotoxicol Teratol201133232933221035540
   PubMed Web of Science ®Google Scholar
• HussainSMHessKLGearhartJMGeissKTSchlagerJJIn vitro toxicity of nanoparticles in BRL 3A rat liver cellsToxicol In Vitro200519797598316125895
   PubMed Web of Science ®Google Scholar
• SmithAMDaveSNieSTrueLGaoXMulticolor quantum dots for molecular diagnostics of cancerExpert Rev Mol Diagn20066223124416512782
   PubMed Web of Science ®Google Scholar
• TangMXingTZengJUnmodified CdSe quantum dots induce elevation of cytoplasmic calcium levels and impairment of functional properties of sodium channels in rat primary cultured hippocampal neuronsEnviron Health Perspect2008116791592218629314
   PubMed Web of Science ®Google Scholar
• HardmanRA toxicologic review of quantum dots: toxicity depends on physiochemical and environmental factorsEnviron Health Perspect2006114216517216451849
   PubMed Web of Science ®Google Scholar
• ChanWCMaxwellDJGaoXBaileyREHanMNieSLuminescent quantum dots for multiplexed biological detection and imagingCurr Opin Biotechnol2002131404611849956
   PubMed Web of Science ®Google Scholar
• DubertretBSkouridesPNorrisDJNoireauxVBrivanlouAHLibchaberAIn vivo imaging of quantum dots encapsulated in phospholipid micellesScience200229855991759176212459582
   PubMed Web of Science ®Google Scholar
• GaoXCuiYLevensonRMChungLWNieSIn vivo cancer targeting and imaging with semiconductor quantum dotsNat Biotechnol200422896997615258594
   PubMed Web of Science ®Google Scholar
• LidkeDSNagyPHeintzmannRQuantum dot ligands provide new insights into erbB/HER receptor-mediated signal transductionNat Biotechnol200422219820314704683
   PubMed Web of Science ®Google Scholar
• WuXLiuHLiuJImmunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dotsNat Biotechnol2003211414612459735
   PubMed Web of Science ®Google Scholar
• HoshinoAFujiokaKOkuTQuantum dots targeted to the assigned organelle in living cellsMicrobiol Immunol2004481298599415611617
   PubMed Web of Science ®Google Scholar
• ShioharaAHoshinoAHanakiKSuzukiKYamamotoKOn the cyto-toxicity caused by quantum dotsMicrobiol Immunol200448966967515383704
   PubMed Web of Science ®Google Scholar
• HoshinoAHanakiKSuzukiKYamamotoKApplications of T-lymphoma labeled with fluorescent quantum dots to cell tracing markers in mouse bodyBiochem Biophys Res Commun20043141465314715244
   PubMed Web of Science ®Google Scholar